CE 253 Pill - yellow capsule/oblong
Pill with imprint CE 253 is Yellow, Capsule/Oblong and has been identified as Repaglinide 2 mg. It is supplied by Chartwell RX, LLC.
Repaglinide is used in the treatment of Type 2 Diabetes and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CE 253
Repaglinide
- Imprint
- CE 253
- Strength
- 2 mg
- Color
- Yellow (yellow to pale yellow, slightly mottled)
- Shape
- Capsule/Oblong (capsule shape)
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Chartwell RX, LLC
- National Drug Code (NDC)
- 62135-0948
Related images for "CE 253"
More about repaglinide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: meglitinides
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.